Literature DB >> 30171016

The complexity of stem cell transplants: can we improve our understanding?

Andrea Bacigalupo1, Francesca Bonifazi2.   

Abstract

Mesh:

Year:  2018        PMID: 30171016      PMCID: PMC6119159          DOI: 10.3324/haematol.2018.198010

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  5 in total

1.  Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial.

Authors:  Birte Friedrichs; André Tichelli; Andrea Bacigalupo; Nigel H Russell; Tapani Ruutu; Michael Y Shapira; Meral Beksac; Dirk Hasenclever; Gérard Socié; Norbert Schmitz
Journal:  Lancet Oncol       Date:  2010-01-30       Impact factor: 41.316

2.  Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Authors:  Bart L Scott; Marcelo C Pasquini; Brent R Logan; Juan Wu; Steven M Devine; David L Porter; Richard T Maziarz; Erica D Warlick; Hugo F Fernandez; Edwin P Alyea; Mehdi Hamadani; Asad Bashey; Sergio Giralt; Nancy L Geller; Eric Leifer; Jennifer Le-Rademacher; Adam M Mendizabal; Mary M Horowitz; H Joachim Deeg; Mitchell E Horwitz
Journal:  J Clin Oncol       Date:  2017-02-13       Impact factor: 44.544

3.  Peripheral-blood stem cells versus bone marrow from unrelated donors.

Authors:  Claudio Anasetti; Brent R Logan; Stephanie J Lee; Edmund K Waller; Daniel J Weisdorf; John R Wingard; Corey S Cutler; Peter Westervelt; Ann Woolfrey; Stephen Couban; Gerhard Ehninger; Laura Johnston; Richard T Maziarz; Michael A Pulsipher; David L Porter; Shin Mineishi; John M McCarty; Shakila P Khan; Paolo Anderlini; William I Bensinger; Susan F Leitman; Scott D Rowley; Christopher Bredeson; Shelly L Carter; Mary M Horowitz; Dennis L Confer
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

4.  Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

Authors:  Martin Bornhäuser; Joachim Kienast; Rudolf Trenschel; Andreas Burchert; Ute Hegenbart; Michael Stadler; Herrad Baurmann; Kerstin Schäfer-Eckart; Ernst Holler; Nicolaus Kröger; Christoph Schmid; Herrmann Einsele; Michael G Kiehl; Wolfgang Hiddemann; Rainer Schwerdtfeger; Stefanie Buchholz; Peter Dreger; Andreas Neubauer; Wolfgang E Berdel; Gerhard Ehninger; Dietrich W Beelen; Johannes Schetelig; Matthias Stelljes
Journal:  Lancet Oncol       Date:  2012-09-07       Impact factor: 41.316

5.  Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects.

Authors:  Daniel Fuerst; Sandra Frank; Carlheinz Mueller; Dietrich W Beelen; Johannes Schetelig; Dietger Niederwieser; Jürgen Finke; Donald Bunjes; Nicolaus Kröger; Christine Neuchel; Chrysanthi Tsamadou; Hubert Schrezenmeier; Jan Beyersmann; Joannis Mytilineos
Journal:  Haematologica       Date:  2018-06-07       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.